J O Moore
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
-
- Chronic Disease Management Strategies 1
- Co-authors
- E A Harden (2 shared papers)Gregg A. Olsen (2 shared papers)B F Haynes (1 shared paper)Michael S. Hershfield (1 shared paper)Joanne Kurtzberg (1 shared paper)Waldmann Ta (1 shared paper)MS Hershfield (1 shared paper)BF Haynes (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Blood (1 paper)Proceedings of the National Academy of Sciences (1 paper)PubMed (5 papers)Surrey Research Insight Open Access (The University of Surrey) (1 paper)
- Partner nations
- United States
In The Last Decade
J O Moore
9 papers receiving 572 citations
Peers
Comparison fields: 5 of 65
- Hematology 423
- Genetics 109
- Public Health, Environmental and Occupational Health 156
- Immunology 110
- Oncology 85
Countries citing papers authored by J O Moore
This map shows the geographic impact of J O Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J O Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J O Moore more than expected).
Fields of papers citing papers by J O Moore
This network shows the impact of papers produced by J O Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J O Moore. The network helps show where J O Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside J O Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 180 | |
| 2 | 1984 | 130 | |
| 3 | 1989 | 126 | |
| 4 | Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors. | 1987 | 61 |
| 5 | Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. | 2006 | 37 |
| 6 | Mitoxantrone in the treatment of relapsed and refractory acute leukemia. | 1984 | 33 |
| 7 | 2009 | 13 | |
| 8 | Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells. | 1988 | 11 |
| 9 | 2004 | 10 |
About J O Moore
J O Moore is a scholar working on Hematology, Epidemiology, Public Health, Environmental and Occupational Health, Immunology and Surgery, having authored 9 papers that have together received 601 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Chronic Disease Management Strategies (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Immunotherapy and Immune Responses (1 paper), Vascular Malformations and Hemangiomas (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Hematology (423 citations), Genetics (109 citations), Public Health, Environmental and Occupational Health (156 citations), Immunology (110 citations) and Oncology (85 citations). J O Moore has collaborated with scholars based in United States. Frequent co-authors include E A Harden, Gregg A. Olsen, B F Haynes, Michael S. Hershfield, Joanne Kurtzberg, Waldmann Ta, Joanne Kurtzberg, MS Hershfield, BF Haynes and C. D. Bloomfield. Their work appears in journals such as Journal of Clinical Oncology, Blood, Proceedings of the National Academy of Sciences, PubMed and Surrey Research Insight Open Access (The University of Surrey).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.